InvestorsHub Logo
Followers 130
Posts 14996
Boards Moderated 1
Alias Born 06/04/2018

Re: None

Thursday, 03/14/2019 9:00:40 AM

Thursday, March 14, 2019 9:00:40 AM

Post# of 320
News: $ESPR Bempedoic Acid Study 1 Results Published in The New England Journal of Medicine Demonstrates Significant LDL-Cholesterol Lowering and Reduced Marker of Underlying Cardiovascular Inflammation, with a Similar Tolerability to Placebo

Bempedoic acid is an oral, once-daily ATP Citrate Lyase (ACL) Inhibitor that reduces cholesterol and fatty acid synthesis in the liver Study 1 is the largest of a comprehensive five Phase 3 study programme investigating the benefits of bempedoic acid in patients requiring additional lo...

Got this from https://marketwirenews.com/news-releases/bempedoic-acid-study-1-results-published-in-the-new-england-journal-of-medicine-demonstrates-significant-ldl-cholesterol-lowering-and-reduced-marker-of-underlying-cardiovascular-inflammation-with-a-similar-tolerability-to-placebo-7846314.html
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ESPR News